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Calcium signalingMore than a billion years ago, bacterial precursors of mitochondria became endosymbionts in what we call
eukaryotic cells today. The true signiﬁcance of the word “endosymbiont” has only become clear to cell
biologists with the discovery that the endoplasmic reticulum (ER) superorganelle dedicates a special domain
for the metabolic interaction with mitochondria. This domain, identiﬁed in all eukaryotic cell systems from
yeast to man and called the mitochondria-associated membrane (MAM), has a distinct proteome, speciﬁc
tethers on the cytosolic face and regulatory proteins in the ER lumen of the ER. The MAM has distinct
biochemical properties and appears as ER tubules closely apposed to mitochondria on electron micrographs.
The functions of the MAM range from lipid metabolism and calcium signaling to inﬂammasome formation.
Consistent with these functions, the MAM is enriched in lipid metabolism enzymes and calcium handling
proteins. During cellular stress situations, like an altered cellular redox state, the MAM alters its set of
regulatory proteins and thus alters MAM functions. Notably, this set prominently comprises ER chaperones
and oxidoreductases that connect protein synthesis and folding inside the ER to mitochondrial metabolism.
Moreover, ER membranes associated with mitochondria also accommodate parts of the machinery that
determines mitochondrial membrane dynamics and connect mitochondria to the cytoskeleton. Together,
these exciting ﬁndings demonstrate that the physiological interactions between the ER and mitochondria
are so bilateral that we are tempted to compare their relationship to the one of a married couple: distinct,
but inseparable and certainly dependent on each other. In this paradigm, the MAM stands for the intracellular
location where the two organelles tie the knot. Resembling “real life”, the happy marriage between the two
organelles prevents the onset of diseases that are characterized by disrupted metabolism and decreased
lifespan, including neurodegeneration and cancer. This article is part of a Special Issue entitled: Mitochondrial
dynamics and physiology.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
More than 20 years ago, Jean Vance biochemically isolated an
intracellular structure from rat liver that she deﬁned as physical contacts
between the endoplasmic reticulum (ER) and mitochondria and termed
this membrane fraction themitochondria-associatedmembrane (MAM)
[1]. At that point, the ER had been recognized formany years as the point
where the secretion of newly synthesized proteins destined to the Golgi
complex and the plasma membrane originates [2,3]. Over the years
however, numerous researchers noted the extraordinary difﬁculty to
biochemically separate ER and mitochondria [4,5], which led
Padmanaban and co-workers in 1982 to suggest the term rough ER–
mitochondria (RERM) subfraction to describe a biochemical platform
where cytochrome c oxidase is synthesized [6]. Yet, between the lateMitochondrial dynamics and
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rights reserved.1950s and early 1980s, the association between the ER andmitochondria
was mostly recognized by electron microscopists, who had determined
with various model systems that up to 80% of mitochondria were in
contact with the rough ER (rER) [7–9]. Electronmicroscopy tomography
led to similar conclusions [10,11].
It was only during the late 1990s that Rizzuto and co-workers
studied the MAM via live-cell imaging with ER and mitochondria-
targeted probes [12]. Studies on lipid metabolism were the ﬁrst to
provide evidence that mitochondria could have functionally relevant
contact sites with the secretory pathway [13]. However, this rather
limited view of MAM functions changed dramatically at the turn of
the millennium with the advent of localized calcium imaging demon-
strating that the ER releases calcium in hotspots directed towards
mitochondria [14,15]. Within mitochondria, calcium regulates cellular
bioenergetics [16]. Today, we know that this organellar contact site is
a critical intracellular signaling platform that determines cellular life
and death and not just lipid homeostasis. Breakthrough papers
published during the past decade have led to the insight that the
MAM is characterized by a special proteome that regulates its formation
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which are characterized by aberrant cellular metabolism or lifespan
such as neurodegenerative diseases, diabetes or cancer, depend on
malfunctioning MAM.
2. Lipid metabolism at the MAM
Studies on lipid synthesizing enzymes such fatty acid CoA ligase had
shown already during the 1970s that both ER andmitochondria contain
their activity [17]. Indeed, fatty acid CoA ligase 4 (FACL4), which
mediates the ligation of fatty acids to coenzymeA (CoA) and is involved
in triacylglycerol synthesis, is used today as one of the most reliable
MAM marker proteins [18,19]. Likewise, early biochemical studies on
triacylglycerol, phosphatidylcholine (PC) and phosphatidylethanol-
amine (PE) showed that the synthesis of these lipids requires enzymatic
activity associated with both the ER andmitochondria, thus postulating
a transport and transfer of lipids between the ER and mitochondria
[13,20,21]. Subsequently, the enzymatic incorporation of serine into
lipids was used to deﬁne a subregion of the ER (i.e., the MAM) [1].
This biochemical separation of ER membranes into mitochondria-
associatedmembranes and puriﬁed ER then showed that the enzymatic
activity of phosphatidylserine synthases 1 and 2 (PSS1, PSS2), two
enzymes that catalyze the synthesis of the PC precursor phospha-
tidylserine (PS), was indeed associated with the MAM, not puriﬁed ER
[22,23]. Mitochondrial phosphatidylserine decarboxylase was shown
to utilize PS to produce phosphatidylethanolamine (PE) [24], in a
distinct pathway to PE production on microsomes by ethanolamine
phosphotransferase [25]. Since one of the ﬁnal enzymes of PC synthesis,
phosphatidylethanolaminemethyltransferase 2 (PEMT2) [26],was again
found to be restricted to the MAM [27], studies by the Vance laboratory
nicely demonstrated that PC synthesis requires a tightly regulated
lipid transfer back and forth between the ER and mitochondria, thus
conﬁrming earlier hypotheses [20]. In other words, the MAM provides
a tight platform for lipid synthesis and lipid transfer between the ER
and mitochondria. These ﬁndings are also consistent with the identity
of several lipid metabolism enzymes as MAM markers: in addition to
FACL4, acyl-coenzyme A:cholesterol acyltransferase-1 (ACAT1/SOAT1)
is a MAM marker protein, since its enzymatic activity is among the
most enriched on the MAM [22]. ACAT1 is a multimembrane-spanning
enzyme that catalyzes the production of cholesterol esters, which are
subsequently incorporated into lipid droplets [28].
Interestingly, the accumulation of lipid metabolism enzymes on the
MAM could be the reason for the formation of a glycosphingolipid-
enriched microdomain fraction at the MAM [29]. This observation and
the identiﬁcation of lipid rafts on the MAM associated with a special
set of proteins [30,31] suggest that lipid synthesis and exchange at the
MAM generate an ER subdomain with unique properties. More recent
progress indicates that the MAM-localized lipid handling may also
have a profound impact on mitochondrial metabolism, since yeast
cells defective in PS biosynthesis become respiration-deﬁcient [32]
andmouse PS decarboxylase knockout cells showalteredmitochondrial
membrane dynamics [33]. The characterization of this functional link
between lipid and mitochondrial metabolism will no doubt be one of
the most exciting aspects of MAM research in the years to come.
3. ER–mitochondria calcium cycling at the MAM
Initially unconnected to this progress in the lipid ﬁeld, studies on
intracellular calcium signaling also reported that the ER and mito-
chondria could be functionally linked. During the 1980s, electron
probe X-ray microanalysis had identiﬁed the ER as the cell's major
calcium storage unit [34], not the mitochondria [35]. Since the import
of calcium into mitochondria boosts the efﬁcacy of mitochondrial
enzymes [16], these ﬁndings raised the question of whether and how
the two organelles exchange calcium in order to allow efﬁcient
mitochondrial metabolism [36].Today, we know that cyclical calcium exchange between the two
organelles is indeed essential for cell life and death [37]. Inside the ER,
free calcium concentrations are close to extracellular calcium concen-
trations, but are orders of magnitude higher than cytosolic calcium
concentrations (0.5 mM versus 100 nM). ER calcium determines the
correct functioning of numerous ER enzymes involved in the manu-
facture of secretory proteins such as those used for N-glycosylation and
oxidative protein folding like calnexin or calreticulin [38]. Although
resting mitochondrial calcium concentrations are signiﬁcantly lower in
the range of hundreds of nM, calcium nonetheless inﬂuences their
major biological mechanisms, including the production of ATP [39–41].
When mitochondria encounter cytosolic calcium concentrations of
above micromolar levels, they can take up calcium to reach intra-
mitochondrial calcium levels of micromolar ranges [42]. Such surges in
intramitochondrial calcium activate numerous mitochondrial enzymes
such as pyruvate dehydrogenase, α-ketoglutarate dehydrogenase and
even enzymes catalyzing oxidative phosphorylation [43]. The apposition
of the ER with mitochondria is a prerequisite for calcium exchange
between the ER and mitochondria, initiated by the massive release of
calcium from the ER that follows the production of inositol-1,4,5-
trisphosphate (IP3) [44], which binds to the IP3 receptor (IP3R) family
proteins [45–47]. Vertebrates have three IP3R family members, but it is
currently not clear how they are functionally distinct [48]. IP3R calcium
release is maximal at cytosolic calcium concentrations of 100–300 nM
[49] and cAMP-dependent protein kinase (PKA) phosphorylation
promotes IP3R1 activity, whereas protein phosphatases 1 and 2A inhibit
it [50]. Therefore, ER calcium release by IP3Rs is regulated by cytosolic
calcium concentrations and their phosphorylation states. Since PKA is
active under reducing, but not under oxidizing conditions in the cytosol
[51], it might be promoting pro-metabolic calcium transfer from the ER
into mitochondria dependent on the cytosolic redox state. Another ER
calcium release mechanism is mediated by skeletal, cardiac and brain
ryanodine receptors. These receptors localize to the sarcoplasmic
reticulum of myocytes and the ER of neurons, respectively [52–54] and
mediate calcium-induced calcium release in cardiac and skeletal muscle
cells [55] and nitric oxide-induced calcium release in neurons [56].
After their intracellular release from the ER, free calcium ions
cannot travel further than 100–500 nm before they typically en-
counter a calcium binding protein [57]. This high concentration of
calcium binding proteins creates microdomains, termed calcium
puffs in the proximity of ER calcium release channels that last for
around 100 ms [58]. It also predicts that enzymes or organelles
responsive to ER-released free calcium should be within a 500 nm
radius of the ER tubules where IP3Rs release calcium [57]. This rule is
expected to extend to mitochondria as well. Hence, in order to take
up calcium vital for their enzymes, mitochondria should either be in
this radius from the ER or should have the ability to approach these
calcium puffs if needed [59]. Indeed, ﬂuorescence microscopy with
calcium-sensitive photo-proteins showed that mitochondrial move-
ment is slowest when cytosolic calcium concentrations are high and
come to a complete stop at >1 μM, as found for example in calcium
puffs released by IP3Rs [60]. Calcium-sensitive probes attached to the
outer mitochondrial membrane have further demonstrated that
mitochondria speciﬁcally approach the ER, but not plasma membrane-
proximal areas, where capacitive calcium inﬂux occurs [61,62]. The
direct implication of these ﬁndings is that it is through the delicate
sensing of ER-released calcium microdomains that mitochondria
determine their positioning within the cell. Moreover, these ﬁndings
predict that the redox and calcium homeostasis of the ER not only
determines ER protein folding, but also mitochondrial positioning as
postulated by us in an earlier review [63].
Following the encounter of high cytosolic calcium concentrations,
mitochondria take up calcium ions released from the ER. Interestingly,
the identity of the protein responsible for this uptake of calcium into
mitochondria has remained a mystery until 2011, when two elegant
studies identiﬁed the long elusive mitochondrial calcium uniporter
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domains is relatively small at 40 kDa, but is part of a large molecular
complex. Consistent with previous observations, the activity of this
newly identiﬁed protein is sensitive to Ru360 and Ruthenium Red.
When examined in live cells, these two compounds are able to block
mitochondrial uptake of ER calcium that has been released through
the IP3R [66]. Applying these compounds to live cells reveals the
intricate relationship between the ER and mitochondria in intra-
cellular calcium homeostasis. While mitochondria normally take up
calcium from ER calcium release hotspots in a very short time frame
following its release [12], in the presence of MCU inhibitors, the
amplitude of ER-associated calcium puffs decreases [67]. These ap-
parently contradictory ﬁndings can only be explained with a sig-
niﬁcant role of mitochondrial calcium uptake towards the regulation
of IP3Rs. Since low or very high cytosolic calcium concentrations act
to diminish IP3R opening and hence reduce ER calcium release [68],
calcium released from the ER thus serves to autoregulate its release
from this storage compartment. These ﬁndings also predict a central
role of the extent of ER–mitochondria apposition, which equals
MAM formation, in cytosolic calcium homeostasis. Thus, ER–mito-
chondria calcium signaling and exchange has to work interde-
pendently to determine the calcium concentrations and the correct
functioning of both the ER and mitochondria.
Once released frommitochondria through the Na+/Ca2+ exchanger
(NCLX) [69], calcium is efﬁciently taken up into the ER by calcium
pumps of the sarco(endo)plasmic reticulum calcium ATPase (SERCA)
family, which close the circle of intracellular calcium signaling between
the ER and mitochondria [70]. The activity of SERCA calcium pumps is
not only required for ER enzymes, it also determines the formation of
calcium oscillating waves in the cytosol following the administration
of IP3R agonists or the activation of G-protein coupled receptors [71].
The SERCA inhibitor thapsigargin slows cytosolic calcium waves and
causes mitochondrial calcium overload that stems from high cytosolic
calcium concentrations [72]. This condition ultimately provokes the
irreversible opening of IP3Rs through the binding of mitochondrial
cytochrome c at the MAM, triggering apoptosis. Thus the MAM can
also accommodate a massive transfer of calcium from the ER to
mitochondria to promote cell death [73] and therefore not only
determines ER–mitochondria calcium signaling, but also the speed of
apoptosis onset [74,75].
4. Lipid metabolism markers of the MAM
It is only in this current decade that the characterization of the
proteome of the MAM has started in earnest [76]. So far, proteomic
studies on the MAM have been a huge challenge for the ﬁeld and
future proteomic approaches will have to ensure that the correct
membrane domains are isolated. The purity of MAM preparations is
often low due to contaminations with mitochondria and other
domains of the ER. Moreover, the MAM itself is to some extent a
moving target. For example, a number of recently published studies
have demonstrated that the extent and the composition of the MAM
changes upon cell stress, in particular ER stress. Under this condition,
the extent of the MAM increases [77], because the ER and mito-
chondria move closer to each other, likely causing an alteration of
the MAM proteome [78]. Conversely, some MAM proteins like
Ero1α leave the MAM when cells are stressed [79]. Cytosolic proteins
that regulate the enrichment of MAM proteins also show different
localization and interactions dependent on cell stress [75]. Therefore,
proteomic studies have to take into account controlled cellular ho-
meostasis. Nevertheless, already today some statements and pre-
dictions can be made about the composition of the MAM (Fig. 1,
Table 1).
Historically, the ﬁrst set of proteins identiﬁed on the MAM
contained proteins of ER-associated lipid metabolism such as PEMT2
and PSS1/2 [23,27]. Another MAM protein is acyl-CoA:diacylglycerolacyltransferase 2 (DGAT2), which targets to the MAM, unlike
DGAT1 [80]. Whereas the MAM enrichment mechanism is not
known for PEMT2 and PSS1/2, in the case of DGAT2 it is a 5 amino
acid mitochondrial-targeting signal that is necessary for enrichment
on the MAM. This targeting signal consists of basic amino acid re-
sidues found close to the ﬁrst transmembrane domain of DGAT2.
Amongst the most reliable MAM markers known today are ACAT1/
SOAT1 and ACS4/FACL4 [18,19,28]. However, ACS4/FACL4 also local-
izes to peroxisomes, which mature from ER membranes [81–83]. It
is currently not known whether ACAT1/SOAT1 also resides outside
of the MAM. Plasmid-based expression of these marker proteins has
led to mixed results: whereas myc-tagged PSS1 is restricted to the
MAM [23], green ﬂuorescent protein (GFP)-tagged PSS1 is also
found on other domains of the ER [84]. This discrepancy has so far
hampered live cell imaging efforts, because GFP-tagging might mask
targeting information required for sorting into the MAM or might
lead to oligomerization that results in mistargeting within the ER
[85].
5. Calcium handling proteins of the MAM
The second large group of proteins localized to the MAM comprises
calcium-handling proteins. Early immunoﬂuorescence studies in
neuronal cells have detected SERCA and IP3R2 on domains of the ER
that are in close proximity of mitochondria [86,87]. However, the
distribution of IP3Rs to domains of the ER is wider than for SERCA2b
in PC12 cells, suggesting that IP3R might lack ER domain targeting
information [88]. Nevertheless, even SERCA2b is not restricted to the
MAM in HeLa cells [89]. Consistent with this impression, quantitative
biochemical approaches have shown that while IP3Rs are certainly
present on the MAM, antibodies against all three IP3R isoforms see
these calcium channels predominantly on microsomes, which contain
the rER [77,90], but also on the nuclear envelope [91]. When narrowing
down to speciﬁc isoforms, IP3R1 and IP3R3 show a distinct intracellular
localization [92]. IP3R1 appears to be found on all domains of the ER
[93–95], whereas IP3R3 is MAM-enriched in CHO [96,97], but not in
mouse embryonic ﬁbroblasts [98] or HeLa cells [89]. IP3R2 has been
reported to cluster upon ionomycin or thapsigargin treatment [206].
Despite these ﬁndings, it is however the IP3R3 form that preferentially
transmits calcium signals from the ER to mitochondria [99]. How can
we explain this apparent contradiction? If IP3R3-mediated calcium
release occurs on the MAM, but IP3R3 is not MAM-restricted, these
ﬁndings suggest that active IP3R3 is speciﬁcally restricted to the MAM.
Thus, despite the involvement of calcium channels and pumps in direct
calcium transfer from the ER to mitochondria on the MAM [59], the
highly localized activity of IP3Rs and SERCA pumps could be regulated
by their post-translational modiﬁcations or protein–protein interac-
tions (see Section 6), leading to an ER-domain-speciﬁc activation or
inactivation of the channels and pumps. For example, this idea is
partially supported by the localization of active, PKA-phosphorylated
IP3R1 to dendrites in neurons, whereas the non-phosphorylated form
is found in the cell body [100].
Both IP3Rs and SERCA interact with numerous regulatory proteins,
which could also determine the domain-speciﬁc activation of these
proteins. Varying amounts of these regulatory proteins have been
detected on the MAM, further suggesting that MAM calcium signaling
might be predominantly determined by the presence of regulatory
proteins on the MAM rather than a preferred presence of calcium-
handling proteins there. One of the best-characterized calcium reg-
ulatory proteins is the sigma-1 receptor [101]. This transmembrane
protein interacts with ion channels at the plasma membrane and
with the IP3R3 on the MAM, where it exerts a chaperone activity
[96]. Normally, sigma-1 receptors associate with the chaperone BiP/
GRP78, but under conditions of low ER calcium or upon the binding
of agonists (e.g., pentazocine), they bind to IP3R3 and prevent
ubiquitin-mediated degradation of this calcium channel. The
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Fig. 1. Diagram of mammalian MAM-enriched proteins, as summarized in Table 1. Only bona ﬁdemammalian MAM proteins are represented, see Table 1. The MAM is a hub for lipid
metabolism (white; top portion of MAM), mitochondrial ﬁssion (orange; indicated by the Drp1 oligomers) and ER chaperones and oxidoreductases (yellow; bottom portion of
MAM). Enrichment of MAM proteins to the vicinity of mitochondria is regulated by lipid modiﬁcation (palmitoylation) and by cytosolic sorting proteins (green; PACS-2, Rab32).
MAM tethering involves mitofusin-2, GRP75 (not shown) and VDAC1 (red). Calcium handling proteins such as SERCA2b, IP3R1 and IP3R3 are found on the MAM (blue), but do
not appear speciﬁcally enriched here. Details and references are found in the text.
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transfer from the ER tomitochondria [96]. The localization of the sigma-
1 receptor to the MAM depends on the lipid composition of the ER. The
depletion of cellular cholesterol leads to relocation of sigma-1 receptors
to other domains of the ER, suggesting that detergent-resistant
membranes are involved in the MAM targeting of this protein [102].
Similar to the sigma-1 receptor, a portion of the promyelocytic
leukemia (PML) tumor suppressor protein associates with IP3Rs at the
MAM [98]. PML physically associates with IP3R3 and promotes its
calcium release activity by allowing the binding of protein phosphatase
2a (PP2a) to the IP3R3, which unlike for IP3R1 [50] results in increased
opening of the IP3R3 and opposes the activity of the kinase Akt [103].
Not much information is currently available on the ER domain
localization pattern of RyR or calcium release channels of the transient
receptor potential cation (TRPC) family. In cardiomyocytes, RyR localize
to the sarcoplasmic reticulum [52] in clusters that are found on the
mitochondria-distal face of the sarcoplasmic reticulum, corresponding
to the location of dyads [91,104]. Also in neurons, calcium release
from RyRs occurs from both the rough and the smooth ER [105].
6. Oxidoreductases and chaperones of the MAM
An important group of MAM proteins are ER protein folding
chaperones and oxidoreductases [63]. Amongst the interactors of
the IP3Rs is the oxidoreductase ERp44, a thioredoxin-related luminal
protein of the ER and the Golgi complex that retains proteins in the ER
if they expose unpaired cysteines, but also promotes immunoglobulin
polymerization [106,107]. ERp44 interacts with IP3R1 most strongly
under reducing conditions and when the ER calcium content is
low [108]. The redox-dependent interaction of ERp44 with IP3R1inhibits ER calcium release, suggesting this interaction is a protective
mechanism that increases ER calcium concentrations under ER stress
and suboptimal ER folding conditions. That this mechanism is directly
tied to the status of oxidative protein folding is evidenced by the
ability of another oxidoreductase, Ero1α, to modulate it [93]. Ero1α
is an enzyme that recharges protein disulﬁde isomerase (PDI), one
of the major catalysts of disulﬁde bond formation [109]. Ero1α
localizes to the MAM under resting conditions, but relocates to
other domains of the ER and becomes secreted, when cells are in a
reducing or hypoxic environment [79]. Ero1α can interact not only
with ERp44, an interaction that helps retain Ero1α in the ER [110],
but also with IP3R1, resulting in the oxidization of this calcium
channel [93,111]. The interaction of Ero1α with oxidized IP3R1
reduces the ER calcium content during resting conditions and
during the onset of apoptosis. ER stress and hypoxia activate the tran-
scription factor CHOP that induces Ero1α, which oxidizes IP3R1 and
removes ERp44 from IP3R1, thus leading to IP3R1 opening [93,111].
Likewise, the MAM targeting of Ero1α likely determines the extent
of MAM calcium handling. We will discuss the medical implications
of these ﬁndings in Section 10.
Another ER folding chaperone that modulates ER calcium sig-
naling and resides on the MAM is calnexin. Calnexin is a lectin that
folds newly synthesized glycoproteins and can interact with ribo-
somes [112,113] as well as with the oxidoreductase ERp57 [114]. A
closely related ER folding assistant involved in the regulation of
ER calcium signaling is calreticulin [115,116], but like ERp57, this
luminal protein is not enriched on the MAM [79]. In contrast to
calreticulin, the localization mechanisms of calnexin to individual
domains of the ER are well characterized. Interaction with ribosomes
requires calnexin phosphorylation by MAPK and protein kinase CK2
Table 1
MAM proteins, their degree of MAM enrichment and remarks. Summary of the most important proteins of this review. Proteins are grouped according to their function. Extent of
MAM enrichment is noted with references where available. Additional notes summarizing information on interacting proteins are indicated on the right, additional references and
details are found in the text.
MAM function Proteins involved MAM enrichment Notes, interactors
Lipid synthesis FACL4 High [18,75] Ligates fatty acids onto coenzyme A; also found on peroxisomes
ACAT1 High [22] Ubiquitous
PSS1/2 High [23] Not ubiquitous, synthesize phosphatidylserine
PEMT2 High [27] Hepatocytes only, methylates phosphatidylethanolamine; also found on lipid droplets
DGAT2 Medium–high [80] Uses 5 amino acid mitochondrial targeting signal to become enriched on MAM
ER calcium release and uptake IP3R1 Low [93,95] Interacts with ERp44 (inhibitor) and Ero1α (activator) as well as VDAC1
IP3R3 Low–medium [89,96,98] Main transmitter of ER–mitochondria calcium signals
Variable localization in non‐neuronal cells?
Interacts with PML and sigma‐1 receptor (activators)
SERCA2b Sometimes MAM enriched [89] Ubiquitous, interacts with calnexin (inhibitor)
Mitochondrial calcium release
and uptake
MCU ? Very little MAM-relevant information available at this moment
NCLX ?
ER calcium regulation ERp44 Low [79] Mostly found on ERES
Ero1α High [79] MAM localization is redox-dependent
Calnexin Medium–high [120] MAM localization is ER stress-regulated; enriched on MAM with PACS-2,
extracted from MAM with Rab32; when on MAM palmitoylated
Presenilin-2 High [122]
Sigma-1 receptor Medium–high [96,102] Interacts with IP3R3; MAM targeting dependent on lipid rafts
Enrichment and removal of
MAM proteins
PACS-2 Low [75] Can shift onto MAM under cell stress
Rab32 Medium [121] Also found on mitochondria
MAM tethering VDAC1 Low [95] Forms a tether with GRP75 and IP3R1; mostly found on mitochondria
Mitofusin-2 Medium [74] Best characterized MAM tether in mammalian systems; mostly found on
mitochondria; interacts with TpMs (inhibitor)
BAP31 ? Interacts physically with Fis1 and functionally with PACS-2
ERMES High [150] Complex so far only detected in yeast (composed of Mmm1p, Mdm12p,
Mdm10p, Mdm34p)
Mitochondrial movement Miro ? Connection with MAM unclear
Gem1p ? Connection with MAM and ERMES unclear
Mitochondrial morphology Drp1 ? Might be highly MAM-enriched when ﬁssion is promoted
Viral proteins UL37 Low–medium [201] Can transfer from ER onto mitochondria
Vpr Low [204] Accumulates on MAM when mitochondrial ﬁssion is blocked
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SERCA2b as shown in Xenopus oocytes [116,117]. This interaction
requires the phosphorylation of the cytosolic domain of calnexin by
ERK and PKC kinases [117,118] and reduces the activity of SERCA2b.
Interestingly, while calnexin mediates protein folding on the rER, it
localizes predominantly to the smooth ER [119] and within this
structure to the MAM [120]. Enrichment of calnexin on the MAM
depends on the interaction with cytosolic phosphofurin-acidic cluster
sorting protein 2 (PACS-2), which binds to non-phosphorylated
calnexin on a cytosolic cluster of acidic amino acids [120]. In addition,
calnexin MAM localization also depends on the activity of the ER Rab
protein Rab32 [121]. Moreover, calnexin needs to be palmitoylated in
order to show MAM enrichment, again suggesting that special lipid
properties of the MAM determine MAM function and targeting [89].
Together, these ﬁndings suggest that calnexin utilizes multiple
mechanisms to target to distinct domains of the ER, depending on
whether it acts as a protein folding chaperone or a modulator of ER
calcium signaling. Future studies will have to determine how ER
homeostasis decides between these functions of calnexin and reg-
ulates its intra-ER targeting.
7. Other proteins of the MAM
Recent publications have led to the exciting ﬁnding that presenilin-2
(PS2) is a MAM protein [122]. PS2, together with presenilin-1, is a part
of the γ-secretase complex (together with APH1, nicastrin and PEN2)
that is required for the cleavage of the amyloid β-precursor protein
(βAPP) [123]. Distinct from presenilin-1 however, the expression level
of PS2 determines the exchange of calcium between the ER and
mitochondria: in cells over-expressing PS2, mitochondrial calcium
uptake following ER calcium release is increased, whereas cells with
low levels of PS2 show reduced ER–mitochondria calcium transfer
[124]. In addition to modulating mitochondrial oxygen consumptionand mitochondrial membrane potential [125], these observations have
far-reaching consequences that might form a molecular basis for
Alzheimer's disease. The expression of disease-associated PS2 mutants
increases the ER–mitochondria interaction so much that it eventually
results in mitochondrial calcium overload and, hence, apoptosis [126].
Like calnexin, PS2 exhibits a cytosolic acidic cluster that is connected
to a protein kinase CK2 site, which is the consensus PACS-2 interaction
motif, thus raising the interesting possibility that PACS-2 regulates PS2
localization like it does in the case of calnexin [127].
The studies on the localization of the autocrine motility factor
receptor (AMFR) suggest that different kinds of MAM might exist.
This receptor for AMF/phosphoglucose isomerase targets to a
subdomain of the smooth ER, which extends from the rER and is in
close contact with mitochondria [128]. Interestingly, this domain
does not label for calnexin, a MAM-enriched chaperone, suggesting
that calnexin and AMFR could target to two distinct kinds of MAM
[129]. Given the peripheral localization of AMFR [128], we are
speculating that these different kinds of MAM might regulate the
functioning of perinuclear and peripheral mitochondria. Nevertheless,
AMFR is also implicated in ER calcium homeostasis, since Cos7 cells
with AMFR levels knocked down show a reduced ability to release
calcium through the IP3R [130].
In summary, recent progress has dramatically increased the
characterization of the MAM proteome and has led to a better
understanding of the function of the MAM. Research from various
laboratories has identiﬁed MAM-enriched lipid metabolism enzymes
and MAM proteins that regulate calcium handling. Surprisingly, the
evidence that calcium-handling proteins themselves are MAM-
enriched is currently far from convincing. Important questions that
the ﬁeld needs to answer are whether active calcium channels and
pumps target to the MAM andwhether by itself, the clustering of active
calcium channels and pumps could act as aMAMnucleation event. Such
a hypothesis is not unfounded, given the ability of calciumpuffs to attract
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on the MAM would then serve to dissolve the MAM structure. For the
moment, this remains an interesting hypothesis that awaits testing.8. Physical connections between the ER and mitochondria in
mammalian cells
As recently as 5 years ago, the only information available on the
identity of MAM tethers was that these tethers should be of
proteinaceous nature, since phospholipid import into mitochondria
decreases upon incubation of the mitochondria and the MAM with
proteinase K in yeast [131]. Moreover, in mammalian cells ER–
mitochondria separation also disrupts calcium transfer [77] and
causes ER stress [75,132]. In addition to protein tethers, another
requirement for the maintenance of the MAM appears to be the
correct retention within the ER of a subset of transmembrane proteins
with cytosolic acidic cluster motifs recognized by PACS-2 [75].
Accordingly, cellswith low levels of PACS-2 showa visible detachment
of mitochondria from the ER and a reduced ability to release calcium
upon IP3R stimulation [75]. However, it is currently unclear what is
the cause and effect of these observations.
Very recent research has demonstrated that MAM protein tether
pairing at the ER and mitochondria has to be a reversible, regulated
mechanism, since ER stress caused by the accumulation of unfolded
proteins increasesMAM tethering thatmanifests itself by an increased
overlap of ER and mitochondria under this condition [77,78]. The
purpose of this increased apposition could be the promotion of
mitochondrial metabolism, likely to increase energy import into the
ER for ER oxidative protein folding, thus alleviating the accumulation
of unfolded proteins in the ER [78]. This promotion of mitochondrial
metabolism requires calcium release from the ER through IP3Rs [16].
Together, these functional links nicely illustrate the symbiotic
relationship between the ER and mitochondria.
Interestingly, the same mechanism is also central to apoptosis
progression, since cytochrome c released from mitochondria following
a calcium overload can bind to IP3R1 [73]. Cell death mediated by Fas
ligand binding to hepatocytes, HeLa cells and Jurkat T lymphoma
[133,134] heavily relies on this protein–protein interaction at the
MAM, thus highlighting the importance of MAM tethers not only for
mitochondrial metabolism, but also for programmed cell death.
Starting in 2006, a rapid succession of breakthrough papers has led
to the identiﬁcation of several ER–mitochondria tethering complexes,
both in yeast and mammalian cells. One of these complexes is based
on the interaction between the voltage-dependent anion channel 1
(VDAC1) and the outer mitochondrial membrane chaperone GRP75
[95]. The interaction of mitochondrial VDAC1with GRP75 strengthens
the functional interaction between the ER and mitochondria by
forming a ternary bridging complex that also comprises IP3R1 on the
ER, thus optimizing calcium transfer from IP3Rs to mitochondria
[95]. Accordingly, GRP75 knockdown reduces calcium transfer from
the ER to mitochondria. VDAC family members localize to the outer
mitochondrial membrane [135]. Through their functions as channels
for, among others, ATP [136], ions and anions [137], and as anchors
for metabolic enzymes (e.g., hexokinase [138]) and Bcl2 family
proteins [135], VDAC family proteins act as central regulators of
mitochondrial metabolism. Interestingly, in particular in neurons,
VDAC1 also localizes to the ER on the membranes that constitute the
MAM (V. Shoshan-Barmatz, personal communication) [139]. The
same observation was made in HeLa cells [89]. At the MAM, VDAC
family proteins have been suggested to serve as an ATP conduit,
which would provide energy for ongoing protein folding inside the
ER [140]. Such a function might even extend into apoptotic calcium
transfer from the ER to mitochondria involving IP3Rs [141], but
whether this mechanism cooperates with previously demonstrated
ones involving cytochrome c remains to be demonstrated.VDAC is not an isolated case of a mitochondrial protein that also
localizes to the ER and is involved in ER–mitochondria tethering.
Mitofusin-2 is a dynamin-related GTPase that is implicated in mito-
chondrial docking and fusion [74,142], but is also found on the MAM,
as shown by the Scorrano laboratory in 2008 [74]. ER–mitochondria
juxtaposition and calcium signaling on the MAM also depends on
mitofusin-2 [74]. Moreover, in one of the most intriguing studies on
the metabolic function of the MAM to date, it was recently shown that
mitofusin-2 ablation in the liver causes ER stress that subsequently
results in glucose intolerance and impaired insulin signaling [132].
MAM-localized mitofusin-2 also interacts with trichoplein/mitostatin
(TpMs). This keratin-binding protein inhibits mitofusin-2 and blocks
mitochondrial fusion while loosening MAM contacts when over-
expressed [143].
Another MAM regulatory protein is the B-cell receptor associated
protein of 31 kDa (BAP31). This protein with three transmembrane
spanning domains acts as an accessory ER protein folding chaperone
for substrates such as the major histocompatibility complex class I or
immunoglobulins [144–146]. However, BAP31 is also an important
regulator of ER–mitochondria crosstalk. Apoptosis induction leads to
the interaction of caspase-8 with BAP31, creating a proteolytic
fragment of BAP31 that promotes calcium release from the ER [147].
The interaction of caspase-8 with BAP31 could depend on the
formation of a complex with the mitochondrial ﬁssion protein Fis1,
which could result in a MAM-localized apoptotic platform [148]. The
sequence of events in this cascade remains to be studied however,
since cleavage of BAP31 appears to precede ER–mitochondria calcium
transfer and apoptosis onset [147]. In addition, BAP31 also interacts
with calnexin, which regulates stress-dependent cleavage of BAP31
by caspase-8 [149]. Interestingly, knockdown of the MAM sorting
protein PACS-2 not only leads to the removal of calnexin from the
MAM, but also to BAP31 cleavage and MAM disruption [75,120].
Together, these studies demonstrate a regulatory role of BAP31 in
ER–mitochondria crosstalk, but also suggest that further research is
needed to understand the sequence of events and whether inter-
actions between BAP31 and its many interactors are a requirement
for MAM signaling mechanisms.
9. The yeast ERMES complex
Following this progress on the identiﬁcation of MAM tethers in
mammalian cells, Kornmann et al. provided an important contribution
with the identiﬁcation of the ER–mitochondria encounter structure
(ERMES) in an elegantly conceived yeast genetic screen [150]. ERMES
comprises the integral ER membrane protein Mmm1p, the peripheral
ER membrane protein Mdm12p, and the two mitochondrial outer
membrane proteins Mdm10p and Mdm34p [150,151]. Previously,
components of ERMES had been suggested to fulﬁll other roles at
mitochondria. For instance, Mdm10p, Mdm12p, and Mmm1p had
been implicated in mitochondrial connections to the actin cytoskeleton
and inmitochondrialmovement [151]. Apparently consistentwith such
hypotheses, the yeast calcium-binding GTPase Gem1p, which is related
to mitochondrial Rho proteins (Miro), had also been identiﬁed as
peripherally associatedwith the ERMES [152,153].Miro GTPases indeed
function as calcium-dependent sensors to control mitochondrial
motility inmammalian cells and seemed thus to back up the hypothesis
of a role of ERMES in mitochondrial movement [154,155]. Similarly, it
has been speculated that ERMES could be part of higher protein
complexes that connect the control of ER and mitochondrial meta-
bolism to the structure and maintenance of mitochondria [156].
However, while a role of ERMES in mitochondrial morphology and
tethering of the ER to mitochondria remains undisputed, a recent
publication has shed serious doubts on some early ﬁndings and in
particular on the role of Gem1p in the regulation of ERMES [157]. In
this detailed study by the Shaw, Rapoport and Voelker laboratories,
ERMES may act as a stable tether between the ER and mitochondria
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mitochondrial movement or mitochondrial interaction with the actin
cytoskeleton. Moreover, Gem1p was found to be dispensable for the
formation of ERMES. At the moment therefore, these ﬁndings suggest
the existence of additional ER–mitochondria tethering mechanisms in
yeast aswell as a need for further research to understand the regulation
and formation of ERMES. One further caveat of the ﬁndings in yeast is
that we currently do not know which mammalian proteins fulﬁll the
function of the ERMES complex and what the role of the known
mammalian tethers is for the yeast MAM. Interestingly however, a
proteomic analysis of yeast MAM has conﬁrmed the presence of some
BiP/GRP78 and VDAC/porin within yeast MAM [153], consistent with
ﬁndings from mammalian cells [89,95,96,139] and suggesting that
indeed, MAM structure and composition in yeast and mammalian
cells might be more similar than currently known.
10. The MAM in health and disease
The vast implications of calcium signaling on various intracellular
signaling mechanisms demonstrate the importance of the MAM for
metabolism and cellular lifespan. Not surprisingly, the MAM has
been proposed as a site that is affected in neurodegenerative diseases
[158]. The role of the MAM in diabetes is an exciting emerging area of
research [132,159]. Proteins implicated in cancer like PML [103], in
the viral manipulation of cellular metabolism [160] and in inﬂam-
mation [161,162] have been detected on the MAM as well, evidencing
the huge potential of future studies in the ﬁeld to further our
understanding of human disease. We will discuss selected mech-
anisms and diseases in this chapter.
Neuronal cells require very large amounts of energy for their
activities and rely almost exclusively on mitochondria as a provider,
in particular in axons and dendrites [163]. Thus, the distribution
and morphology of mitochondria is a critical determinant of neuronal
survival [164,165]. The role of the MAM for neuronal survival is based
on the presence of smooth or rough ER all the way throughout axons
and dendrites [166]. Consistent with this, a number of ER structural
proteins can give rise to neuronal defects if mutated. Notably,
reticulon-4, also known as neurite outgrowth inhibitor (Nogo),
promotes ER tubulation [167], but might also inﬂuence the calcium-
dependent apposition between the ER and mitochondria [168]. Such
a function could potentially be assigned to many enzymes regulating
ER tubulation, such as receptor expression enhancing protein 1
(REEP1) that regulates ER network formation, but also mitochondrial
membrane dynamics [169,170]. Interestingly, REEP1 is a genetic
cause for hereditary spastic paraplegia [171], which is reminiscent
of the well known role of the microtubule severing protein spastin
in both the connection of ER tubules to the cytoskeleton [170], but
also the trafﬁcking of mitochondria along axons [172,173].
The dynamic membrane contacts at the MAM could require the
calcium-dependent Ras GTPases Miro-1 and Miro-2 that promote
mitochondrial clustering when active by forming a link between
mitochondria and microtubules [174] and kinesin heavy chain
(KIF5) [154]. These calcium-dependent interactions may provide a
mechanism behind the ability of mitochondria to move towards
calcium puffs released by IP3Rs [60]. The Miro protein complex also
interacts with mitofusin-2 [175], which is also essential for the
transport of mitochondria along the axons [175]. Mitofusin-2
mutations lead to Charcot Marie Tooth type 2A disease, a peripheral
neuropathy [176,177], wherein the longest neurons in patients die
[178]. Consistent with the potential involvement of the MAM, it has
been proposed that a mitochondrial transport defect leads to the
disease [176]. This defect could stem from an inability of mitofusin-
2 mutated neurons to form the MAM or from an inability of
mitofusin-2 mutants to interact with kinesin [179].
Another neurodegenerative disease tied to the MAM is Alzheimer's
disease [158]. Alzheimer's disease-associated mutations in PS2lead to reduced ER calcium content and even further increased ER–
mitochondria calcium transfer when compared to wild type over-
expression [126]. The increased ER–mitochondria calcium communica-
tion has dramatic consequences in cells with mutant PS2. These cells
showmarkedly increased apoptosis susceptibility, which could explain
the aberrant neurodegeneration in Alzheimer's patients, thus leading to
the provocative proposal by Eric Schon that Alzheimer's is actually a
disease of a malfunctioning MAM [124,158]. Consistent with a role of
the MAM for maintaining neuronal function, PS2 is needed for the
normal oxygen consumption and mitochondrial membrane potential
of neurons [125].
Another important connection between the MAM and neuronal
function is based on dynamin-related protein 1 (Drp1). Recently, ER
tubules have been suggested as the means by which Drp1 oligomers
constrict mitochondrial structures [180]. The intracellular localization
of Drp1 has remained disputed over the years with reports ranging
from ER [181] to mitochondria [182]. Its association with the MAM
could potentially reconcile these discrepancies, but such a formal
demonstration currently awaits publication. That the MAM plays an
important role for Drp1 is evidenced by its relationship with the
ER–mitochondria-associated Rab32: our laboratory has shown that
inactivation of Rab32 mislocalizes and inactivates Drp1 [121].
Multiple links exist between Drp1 and neurodegeneration [183]. For
example, Alzheimer's patient brains exhibit increased mitochondrial
ﬁssion activity and express higher levels of Drp1 in an Aβ-
dependent manner [184,185]. In Parkinson's disease, loss of function
mutations in the PTEN-induced putative kinase 1 (PINK1) and in
parkin lead to increased mitochondrial fragmentation catalyzed by
Drp1 that also coincides with an arrest of mitochondrial motility
[186,187]. These effects are based on the kinase activity of PINK1
and a ubiquitin ligase activity of parkin [188], which lead to altered
phosphorylation and hence activity of Drp1 [189,190]. Parkin is also
able to ubiquitinate Drp1 directly, thus mediating its degradation
[191]. Since mitofusin-2 and Drp1 are critically involved in MAM
function and also localize to ER–mitochondria contact sites, the sum
of these ﬁndings amply demonstrates the prominent role of the
MAM in the etiology of numerous neurodegenerative diseases.
The past decade has also seen the association of a number of MAM
proteins with cancer and tumorigenesis. For example, the cytosolic
sorting protein PACS-2 that maintains MAM integrity and ER–
mitochondria calcium exchange is mutated in as much as 40% of
sporadic colorectal cancer biopsies and could thus act as a tumor
suppressor [192]. However, the maintenance of the MAM and its
calcium signaling platform is not a clear hallmark of cancer, since the
tumor suppressor PML actually promotes the opposite: PML interacts
with IP3R3, leading to its hyper-phosphorylation, which results in
reduced ER–mitochondria calcium ﬂux and apoptosis resistance [103].
Similarly, the suspected tumor suppressor trichoplein/mitostatin
(TpMs) inhibits mitofusin-2 and hence MAM formation, but is
downregulated or mutated in a number of types of cancer [193,194].
Thus, while proteins regulating the MAM are clearly associated with
cancer, future research will have to elucidate which functional aspect
of the MAM is most critical for tumorigenesis: apoptosis onset or the
maintenance of cancer cell metabolism.
Another important group of MAM regulatory proteins are
chaperones and oxidoreductases of the ER such as BiP/GRP78,
ERp44, Ero1α, and calnexin [93,96,108,111,117,120]. All of these are
central players in ER–mitochondria calcium ﬂux [63]. Hypoxic cancer
tissue shows HIF1α-dependent upregulation of Ero1α, which leads
to tumor cell proliferation [195]. Given its redox-dependent
relationship with ERp44 [106,108], high expression of Ero1α in
hypoxic cancer tissue could thus result in altered IP3R calcium
signaling. Future research will have to determine whether this results
in increased activity of IP3R [93], or simply in increased secretion of
Ero1α [79]. In mouse models, it has been shown that loss of Ero1α
function leads to reduced peak amplitude of cardiomyocyte calcium
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[196]. Thus, increased Ero1α expression levels could be associated
with overproliferation resulting in tumors, whereas heart disease
progression might also be characterized by an increase of Ero1α
expression.
This latter aspect is also important for the MAM-associated
regulation of calcium signaling by SERCA. The cellular redox state
plays an important role in the regulation of SERCA activity by promoting
multiple, redox-dependent modiﬁcations on Cys674, which is present
in both SERCA2a and SERCA2b. Whereas mild oxidation leads to the
glutathionylation of Cys674 and increases pump activity [197], chronic
oxidation oxidizes other cysteines and causes irreversible sulfonation of
Cys674 that results in a complete stop of calcium pumping [198].
Recently it has been shown that oxidative inhibition of SERCA by
exposure of a modest oxidative stress (100 μM H2O2) in cardiac
myocytes causes a contractile phenotype characterized by reduced
contractile amplitude, reduced amplitude of the intracellular calcium
transient, and depletion of the sarcoplasmic reticulum calcium [199].
Conversely, nitroxyl and peroxynitrite increase calcium cycling in
cardiac myocytes via S-glutathionylation of SERCA and its subsequent
activation [197]. These results indicate how cellular redox and redox-
sensitive enzymes could directly modulate the calcium signaling
function of the MAM.
In addition to modulating MAM calcium signaling, the Tschopp
laboratory has recently made the exciting discovery that reactive
oxygen species (ROS) lead to the activation of NOD-like receptor
protein 3 (NLRP3) inﬂammasomes [162]. This activation coincides
with the shift of thioredoxin-interacting protein (TXNIP) from cytosolic
thioredoxin 1 to the NLRP3 inﬂammasome on the MAM. Increased ROS
production inside mitochondria due to extra- or intracellular stress
triggers is a prerequisite for this observation [161]. Interestingly, the
MAM structural component VDAC is integral to this response, since
RNAi-mediated VDAC1/2 knockdown abrogates inﬂammasome
formation in response to monosodium urate, alum or nigericin. Similar
to apoptosome formation that requires the release of mitochondrial
cytochrome c, ROS-triggered inﬂammasome activation might require
the release of mitochondrial DNA, providing an additional potential
role for the MAM [200].
Given these important roles of the MAM for calcium signaling,
apoptosis and inﬂammasome activation, it comes as no surprise that
numerous viral proteins target this structure. One prominent and
well-described example is the human cytomegalovirus glycoprotein
UL37 exon 1 [201]. Unless this protein is expressed, cytomegaloviruses
induce apoptosis of infected cells [202]. This glycoprotein targets to the
MAM with two mitochondrial targeting signals [203] and is able to
reduce ER calcium content, possibly by increasing the targeting of
GRP75 to the VDAC/IP3R/GRP75 ternary complex [201] or by mod-
ulating the amount of calcium-regulating chaperones and oxido-
reductases such as BiP on the MAM [76]. The MAM also houses the
cytosolic pathogen recognition receptor RIG-1 that triggers an
immunity signaling cascade upon viral infection [84]. More recently,
HIV-1 Vpr has been suggested to disrupt the MAM by reducing
mitofusin-2 and Drp1 protein levels [204]. Given the complexity of
MAM functions that promote cellular metabolism, but also apoptosis,
numerous reasons exist for MAM interference by viral proteins. Future
research in this exciting ﬁeld will have to address which aspect is
targeted for individual examples.
11. Conclusions
The ER forms a superorganelle with distinct domains performing
speciﬁc functions [205]. Compared to the rER, the MAM is still not
the best deﬁned or characterized ER subdomain. However, during
the past decade, a series of important papers has been published
that demonstrates a central role of the MAM in the regulation of
cellular metabolism [16,78], apoptosis progression [73], intracellularcalciumhomeostasis [74], themaintenance of ER redox conditions [75]
and mitochondrial membrane dynamics [74,180]. After the initial
discovery of lipid synthesizing enzymes on the MAM [1], we now
know that the MAM proteome is much more complex and comprises
tethering proteins that can localize to both the ER and mitochondria
[74,95], ER chaperones and oxidoreductases that regulate its function
[79,89,96] as well as ER calcium channels and pumps. Importantly, we
start to understand that some of these proteins including IP3R and
SERCA are only enriched on the MAM to some extent in a temporary
and cell-stress dependent manner. Therefore, future research will
have to describe more MAM enrichment mechanisms along the lines
of the cytosolic sorting proteins PACS-2 and Rab32. Areas of
controversy in the ﬁeld currently comprise the role of the MAM in
mitochondrial membrane dynamics (e.g., Drp1, BAP31), the identity
and function of MAM tethers (e.g., ERMES) and the extent to which
MAM proteins target to this domain, in particular calcium handling
proteins and GFP fusion proteins. Also, although so far not dem-
onstrated, a tempting possibility exists that the MAM could accom-
modate a partial fusion and protein exchange between ER and
mitochondrial membranes. No doubt the coming 20 years of MAM
research will prove as exciting as the ﬁrst 20 and will give important
insight into the biogenesis of numerous important human diseases,
including neurodegeneration and cancer.
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